Glaucoma management across 13 countries in Central, Eastern and Southeastern Europe: an exploratory survey.

Authors

Natalia Palarie, Fidan Aghayeva, Ewa Kosior-Jarecka, Nino Kobakhidze, Maryana Kovalska, Makedonka Atanasovska-Velkovska, Karolína Skorkovská, Lidija Kelava, Ilir Osmani, Lala Ćeklić, Adriana Chicu, Neda Sergeeva, Qëndresë Daka

Published in

International ophthalmology. Volume 46. Issue 1. Sep 28, 2026. Epub Sep 28, 2026.

Abstract

To describe glaucoma management practices, access and reimbursement across 13 countries in Central, Eastern and Southeastern Europe (CESE).
A structured questionnaire adapted from the 2015 European Glaucoma Society (EGS) survey was completed by one ophthalmologist with knowledge of prevailing practice and regulation in each participating country. The survey covered areas such as patient organization availability, national guidelines, residency training, access to diagnostic tools, treatment protocols, surgical techniques, laser treatments, minimally invasive glaucoma surgery (MIGS) and moderately invasive bleb-forming shunts (MIBS), and healthcare coverage. Responses were summarized descriptively.
Ophthalmology residency programs varied in duration with limited surgical training access and no subspecialty glaucoma fellowships. Diagnostic protocols were relatively standardized but showed variability in tool availability and usage. Insurance coverage ranged from full coverage to none. Medical monotherapy was usually the initial treatment. Laser treatments were variably accessible, with frequent use reported in some countries and limited availability in others. The availability of MIGS and MIBS was reported as limited in most countries, with their use generally being rare or occasional.
This exploratory key-informant survey identified shared approaches alongside marked differences in training, reimbursement, diagnostic access and surgical availability. Findings represent reported practices and should not be interpreted as nationally representative estimates.

PMID:
42802240
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.